![Fiona Angela Marston](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fiona Angela Marston
Directeur Général chez
Erebagen Ltd.
Profil
Fiona Angela Olinda Marston is the founder of Novacta Biosystems Ltd. Current jobs include Chief Executive Officer at Erebagen Ltd. since 2020 and Director at Biotechnology & Biological Sciences Research Council.
Former jobs include Chief Executive Officer at Absynth Biologics Ltd., Non-Executive Director at Medella Therapeutics Ltd., and Senior Investment Manager at H2O Venture Partners Ltd. from 2008 to 2011.
Education includes an undergraduate degree from the University of East Anglia, an MBA from London Business School, and a doctorate from the University of Kent.
Postes actifs de Fiona Angela Marston
| Sociétés | Poste | Début |
|---|---|---|
Biotechnology & Biological Sciences Research Council
 Biotechnology & Biological Sciences Research Council Miscellaneous Commercial ServicesCommercial Services Operates a funding agency for academic research and training | Directeur/Membre du Conseil | - |
Erebagen Ltd.
 Erebagen Ltd. BiotechnologyHealth Technology Develops novel bioactive products from microbes by activating previously silent gene clusters | Directeur Général | 30/03/2020 |
Anciens postes connus de Fiona Angela Marston
| Sociétés | Poste | Fin |
|---|---|---|
H2O Venture Partners Ltd.
 H2O Venture Partners Ltd. Investment ManagersFinance H2O Venture Partners invests in companies located in South East, South and Midlands areas of the United Kingdom. The firm focuses on the technology sector. It participates in buyouts transactions. | Private Equity Investor | 01/07/2011 |
Absynth Biologics Ltd.
 Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies | Directeur Général | - |
Medella Therapeutics Ltd.
 Medella Therapeutics Ltd. BiotechnologyHealth Technology Develops monoclonal antibody drugs for cancer | Directeur/Membre du Conseil | - |
Novacta Biosystems Ltd.
 Novacta Biosystems Ltd. BiotechnologyHealth Technology Discovers and develops drugs for treatment of bacterial infections | Fondateur | - |
Formation de Fiona Angela Marston
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
University of East Anglia
 University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotechnology & Biological Sciences Research Council
Biotechnology & Biological Sciences Research Council Miscellaneous Commercial ServicesCommercial Services Operates a funding agency for academic research and training | Commercial Services |
Novacta Biosystems Ltd.
Novacta Biosystems Ltd. BiotechnologyHealth Technology Discovers and develops drugs for treatment of bacterial infections | Health Technology |
Medella Therapeutics Ltd.
Medella Therapeutics Ltd. BiotechnologyHealth Technology Develops monoclonal antibody drugs for cancer | Health Technology |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Develops and manufactures immunological prophylaxis, novel vaccines and therapies | Health Technology |
H2O Venture Partners Ltd.
H2O Venture Partners Ltd. Investment ManagersFinance H2O Venture Partners invests in companies located in South East, South and Midlands areas of the United Kingdom. The firm focuses on the technology sector. It participates in buyouts transactions. | Finance |
University of Kent
 University of Kent Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Erebagen Ltd.
Erebagen Ltd. BiotechnologyHealth Technology Develops novel bioactive products from microbes by activating previously silent gene clusters | Health Technology |
